Intravenous immunoglobulin is used to treat many medical conditions, from chronic to acutely life-threatening, and its supply recently shifted abruptly and indefinitely, says Dr. Paul Biddinger ...

A rare Guillain-Barré syndrome recurrence caused nausea with no motor symptoms but was treated successfully with intravenous ...

Intravenous Immunoglobulin Market: Segmental Overview. Based on the type, the intravenous immunoglobulin market is segmented into IgG, IgM, IgA, IgE, and IgD.

High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019. In Open forum infectious diseases (Vol. 7, No. 3, p. ofaa102). US: Oxford ...

High-dose intravenous immunoglobulin G and usual heparin anticoagulation for urgent cardiac surgery in a patient with severe autoimmune heparin-induced thrombocytopenia, Journal of Thrombosis and ...

Vancouver, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The global Intravenous Immunoglobulin (IVIG) market size was USD 12.10 Billion in 2022 and is expected to register a revenue CAGR of 7.5% during the ...

The intravenous immunoglobulin (IVIG) market is experiencing significant growth due to the rising prevalence of autoimmune diseases, immune deficiencies, and neurological disorders. Advancements ...

Intravenous immunoglobulin (IVIG) is used to replenish immunoglobulins in hypogammaglobulinemia (HG) caused by hematologic malignancies (HM) or their treatment (autologous stem-cell transplantation ...

Intravenous Immunoglobulin Likely More Effective Than Corticosteroids in Chronic Inflammatory Demyelinating Polyneuropathy. S. Andrew Josephson, MD. Disclosures. AccessMedicine from McGraw-Hill .

The short- and long-term prognoses for patients with dermatomyositis may be improved by the addition of intravenous immunoglobulin to their treatments, according to recent results. In a cohort of ...

The Intravenous Immunoglobulin market has experienced remarkable growth over recent years, driven by advancements in medical technologies, increasing awareness of immune-related disorders, and rising ...